Hazlett, Burt & Watson’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$37K Hold
100
– – 0.01% 518
2026
Q2
$36K Hold
100
– – 0.01% 517
2026
Q1
$25K Hold
100
– – 0.01% 553
2025
Q4
$28K Hold
100
– – 0.01% 544
2025
Q3
$26K Hold
100
– – 0.01% 520
2025
Q2
$22K Hold
100
– – 0.01% 490
2025
Q1
$22K Hold
100
– – 0.01% 482
2024
Q4
$33K Hold
100
– – 0.01% 407
2024
Q3
$30K Hold
100
– – 0.01% 422
2024
Q2
$33K Hold
100
– – 0.02% 392
2024
Q1
$40K Buy
+100
New +$37K 0.02% 360

Other funds holding WST

Hazlett, Burt & Watson's WST Position: Q3 2026 in Review

Hazlett, Burt & Watson held its West Pharmaceutical (WST) position steady in Q3 2026 at 100 shares worth $37K. The position accounts for 0.01% of the portfolio, ranked #518.

Hazlett, Burt & Watson first reported a position in WST in Q1 2024 and has held it in 11 quarters since. The position peaked at $40K in Q1 2024. 875 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • Hazlett, Burt & Watson held 100 shares of West Pharmaceutical worth $37K as of Q3 2026.
  • Hazlett, Burt & Watson left its West Pharmaceutical share count unchanged in Q3 2026.
  • West Pharmaceutical made up 0.01% of Hazlett, Burt & Watson's portfolio in Q3 2026, its #518 holding.
  • Hazlett, Burt & Watson first reported a position in West Pharmaceutical in Q1 2024 and has held it in 11 quarters since.
  • Hazlett, Burt & Watson's West Pharmaceutical position peaked at $40K in Q1 2024.
  • 875 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Hazlett, Burt & Watson's 13F filing for Q3 2026, filed 4 Nov 2026.